Recombinant Human UL16-binding protein 1 (ULBP1) (Active)

Recombinant Human UL16-binding protein 1 (ULBP1) (Active)

Catalog No. CSB-MP887177HU
Target ULBP1

Product Details

Purity ≥ 90% as determined by SDS-PAGE.
Endotoxin Less than 1.0 EU/ug as determined by LAL method.
Target Names ULBP1
UniProt No. Q9BZM6
Alternative Names (ALCAN-beta) (NKG2D ligand 1) (N2DL-1) (NKG2DL1) (Retinoic acid early transcript 1I)
Molecular Characterization
Source / Host Mammalian cell
Tag C-terminal hFc1-Myc-tagged
Protein Length Full Length of Mature Protein
Molecular Weight 52.4 kDa
Formulation Lyophilized from a 0.2 μm sterile filtered PBS, 6% Trehalose, pH 7.4
Reconstitution We recommend briefly centrifuging the vial prior to opening to bring the contents to the bottom. Reconstitute the lyophilized protein in sterile deionized water to a recommended concentration of 0.1–1.0 mg/mL. If used immediately after reconstitution, glycerol is not required. If not for immediate use, after the protein is completely dissolved, add glycerol to a final concentration of 5%–50% (default: 50%), aliquot as needed, and store at -20℃/-80℃ for long-term storage. If dilution is needed during subsequent use, dilute with the same buffer as the protein, but without stabilizers (e.g., glycerol, trehalose, etc).
Troubleshooting and FAQs
Protein FAQs
Storage Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. Avoid
repeated freeze-thaw
cycles.
Lead Time 3-7 business days

Description

ULBP1 is a stress-induced ligand for the NKG2D receptor that plays a central role in activating NK cell–mediated cytotoxicity against transformed cells, making it a key target in immuno-oncology research. This recombinant human ULBP1, spanning residues 26–216 of the mature protein with a C-terminal hFc1-Myc tag, demonstrates robust binding to immobilized KLRK1 by functional ELISA (EC50 of 228.5–427.6 ng/ml) and a high-affinity interaction with KLRK1 measured at a KD of 2.27 nM by LSPR, confirming that the protein is appropriate for receptor-ligand binding assays, NKG2D signaling studies, and… Read more